Suppr超能文献

针对脑型和非脑型疟疾患者中恶性疟原虫血液期抗原的免疫沉淀抗体。

Immunoprecipitating antibodies against blood stage antigens of Plasmodium falciparum in cerebral and non-cerebral malaria patients.

作者信息

Thammapalerd N, Tharavanij S, Patarapotikul J, Looareesuwan S

机构信息

Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

出版信息

Southeast Asian J Trop Med Public Health. 1987 Jun;18(2):171-8.

PMID:3313734
Abstract

Immunoprecipitating antibodies were determined in paired sera of 31 patients with cerebral malaria (CM), of whom 14 had complicated cerebral malaria (CCM) and 17 had uncomplicated cerebral malaria (UCCM), 15 single specimens of patients with acute uncomplicated (AM) malaria taken on the day of admission and 8 healthy controls. All but one patient were admitted within the first three days of the onset of fever. More than 20 precipitating bands were observed, of which the predominating molecules were the Mr greater than 200, 180, 157, 135, 130, 115, 103, 96, 91, 73, 71, 61, 49, 45, 43, 41 and 14.3 Kd. In general, there were no significant differences in the positive rates among the AM, CCM and UCCM patients except for the pf135 Kd molecule which was more frequently reactive in UCCM patients than the AM and CCM patients. If immunological naiveness in term of protective immunity is the feature in CM patients, the immunoprecipitation test used is inadequate to demonstrate the fundamental differences in immune responses between CM and AM patients.

摘要

在31例脑型疟(CM)患者的配对血清中检测了免疫沉淀抗体,其中14例为复杂脑型疟(CCM),17例为非复杂脑型疟(UCCM);还检测了15例急性非复杂疟(AM)患者入院当天采集的单份标本以及8名健康对照者的血清。除1例患者外,所有患者均在发热开始后的头三天内入院。观察到20多条沉淀带,其中主要分子的分子量分别大于200、180、157、135、130、115、103、96、91、73、71、61、49、45、43、41和14.3 Kd。总体而言,AM、CCM和UCCM患者之间的阳性率没有显著差异,但pf135 Kd分子在UCCM患者中的反应性比AM和CCM患者更频繁。如果从保护性免疫的角度来看,CM患者具有免疫幼稚性这一特征,那么所使用的免疫沉淀试验不足以证明CM患者和AM患者在免疫反应上的根本差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验